Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01492543
Recruitment Status : Unknown
Verified March 2013 by Binghe Xu, Chinese Academy of Medical Sciences.
Recruitment status was:  Recruiting
First Posted : December 15, 2011
Last Update Posted : March 15, 2013
Beijing Cancer Hospital
Beijing Chao Yang Hospital
Chinese PLA General Hospital
China-Japan Friendship Hospital
Tianjin Medical University Cancer Institute and Hospital
Hebei Tumor Hospital
Information provided by (Responsible Party):
Binghe Xu, Chinese Academy of Medical Sciences

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : April 2014
  Estimated Study Completion Date : October 2014